Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.059 CHF | +0.34% | +7.27% | +43.90% |
04-17 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
04-17 | Swiss Court OKs Moratorium Extension for Spexis | MT |
Business Summary
Number of employees: 28
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Wager
CEO | Chief Executive Officer | 62 | 29/12/21 |
Martin Jakobovic
DFI | Director of Finance/CFO | - | - |
Stephan Wehselau
COO | Chief Operating Officer | 55 | 29/12/21 |
Chief Tech/Sci/R&D Officer | 68 | 29/12/21 | |
Muriel Fleming
HRO | Human Resources Officer | - | 11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dan Hartman
BRD | Director/Board Member | 62 | 29/12/21 |
Dennis Ausiello
BRD | Director/Board Member | 78 | 29/12/21 |
Kuno Sommer
BRD | Director/Board Member | 68 | 31/08/12 |
Jeffrey Wager
CEO | Chief Executive Officer | 62 | 29/12/21 |
Robert Clarke
BRD | Director/Board Member | 56 | 29/12/21 |
Bernard Bollag
BRD | Director/Board Member | 63 | 31/05/13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 67,664,495 | 31,538,191 ( 46.61 %) | 0 | 46.61 % |
Company contact information
Sector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+43.90% | 4.36M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- POLN Stock
- Company Spexis AG